Global Cardiopulmonary Exercise Testing Market Growth to be Propelled by Rise in the Research and Development on Cardiovascular Exercise Testing Devices by CAGR of ~5% During 2022 – 2031
Kenneth
Research published a report titled “Cardiopulmonary Exercise Testing Market: Global Demand Analysis &
Opportunity Outlook 2031” which delivers detailed overview of the
global
cardiopulmonary exercise testing market in terms of market segmentation by end-user,
product type, and by region.
Further,
for the in-depth analysis, the report encompasses the industry growth
indicators, restraints, supply and demand risk, along with detailed discussion
on current and future market trends that are associated with the growth of the
market.
The global cardiopulmonary exercise testing market is
expected to grow at ~5% CAGR over the forecast period,
i.e., 2022-2031. The market is segmented by end-user into clinics & hospitals, ambulatory centers, and diagnostic
centers, out of which, the clinics & hospitals segment is anticipated to
hold the largest share over the forecast period owing to the rise in the number
of patients arriving for treatment in the hospital and its high financial
capability to keep updated technology for the diagnosis of the patient.
The rise in the research and development on cardiovascular
exercise testing devices to detect the disease at an earlier stage is projected
to increase the growth of the market. Moreover, a surge in the subsidies
provided by the government for the advancement of healthcare infrastructure is
further anticipated to spur the growth of the global cardiopulmonary
exercise testing systems market.
Geographically,
the global cardiopulmonary exercise testing market is segmented
into five major regions including North
America, Europe, Asia Pacific, Latin America and Middle East & Africa
region. Out of them, the market in the
North America region is estimated to witness noteworthy growth by the end of
2031 owing to an increase in the number of heart disease cases, and rising
awareness among the people related to the cardiopulmonary exercise testing
system for diagnosis of the disease.
The
research is global in nature and covers detailed analysis on the market in
North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain,
Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden,
Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America
(Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India,
Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand,
Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE,
Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East
and Africa). In addition, analysis comprising market size, Y-O-Y growth &
opportunity analysis, market players’ competitive study, investment
opportunities, demand for future outlook etc. has also been covered and
displayed in the research report.
Increase in the Number of Heart Disease Cases
Across the Globe to Drive the Growth of the Market
According
to the World Health Organization, nearly 17.9 million people died from
cardiovascular disease, accounting for 32% of all global deaths in 2019
Backed by
the increase in the number of disease cases across the globe, there has been a growing
demand for cardiopulmonary exercise testing devices for the diagnosis of
diseases. Therefore, it is anticipated to drive the growth of the global
cardiopulmonary exercise testing systems market.
However, the
high cost of cardiopulmonary exercise testing systems and a lack of skilled
workers for operating the systems are
expected to operate as key restraint to the growth of global
cardiopulmonary exercise market over the forecast period.
This
report also provides the existing competitive scenario of some of the key
players of the global cardiopulmonary exercise testing market which includes company
profiling of NIHON KOHDEN
CORPORATION, MGC Diagnostics Corporation, VYAIRE MEDICAL, INC., Koninklijke
Philips N.V., Schiller Americas, inc, General Electric Company, COSMED srl,
Therma Fisher Scientific, Halma plc, Masimo, and others. The profiling
enfolds key information of the companies which encompasses business overview,
products and services, key financials and recent news and developments. On the
whole, the report depicts detailed overview of the global cardiopulmonary exercise
testing market that
will help industry consultants, equipment manufacturers, existing players
searching for expansion opportunities, new players searching possibilities and
other stakeholders to align their market centric strategies according to the
ongoing and expected trends in the future.
Request Report Sample@ https://www.kennethresearch.com/sample-request-10077079
Kenneth Research is a leading service provider for
strategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision in order to avoid future uncertainties.
Contact for more
Info:
AJ Daniel
Email: sales@kennethresearch.com
U.S. Phone: +1 313 462 0609
Comments
Post a Comment